Panayiotis Nicolaou Varelas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Panayiotis Nicolaou Varelas has a total of 223 co-authors. Here are the top co-authors by number of shared publications:
Tamer Abdelhak
Department of Neurology, Albany Medical College, Albany, NY
10 shared publicationsLotfi Hacein-Bey
Interventional Neuroradiology and Neuroradiology, Department of Medical Imaging, Sutter Health, Sacramento, CA 95815, USA; Radiology Department, University of California Davis Medical School of Medicine, 4860 Y Street, Sacramento, CA 95817, USA
9 shared publicationsMarianna V. Spanaki
Henry Ford Hospital
8 shared publicationsLonni Schultz
Departments of Neurology, Neurosurgery and Public Health Sciences, Henry Ford Hospital, Detroit, Michigan, USA
5 shared publicationsMarianna Spanaki
Henry Ford Hospital & Henry Ford West Bloomfield Hospital
5 shared publicationsMohammed Rehman
Departments of Neurology, Neurosciences Critical Care Units, Henry Ford Hospital, Detroit, MI, USA
5 shared publications
Latest Publications
- 21 August 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 257, 109117
Anti-IgLON-5 disease presenting with axial dystonia and acetazolamide-responsive apnea
- 21 August 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 257, 109117
Anti-IgLON-5 disease presenting with axial dystonia and acetazolamide-responsive apnea
- Open Access
- 11 April 2025
- Published by Springer Nature in Neurocritical Care
- Vol. 42 (3) , 747-750
Apnea Testing in Brain Death Due to Primary Posterior Fossa Injury
- 11 April 2025
- Published by Springer Nature in Neurocritical Care
- Vol. 42 (3) , 747-750
Open AccessApnea Testing in Brain Death Due to Primary Posterior Fossa Injury
- 3 April 2025
- Published by Springer Nature in Neurocritical Care
- p. 1-9
Longitudinal Improvement in Respiratory Function Following Plasma Exchange in Patients with Severe Myasthenia Gravis
Background There are no data on the effect size and timing of plasma exchange (PLEX) in patients with myasthenic crisis (MC). Methods We retrospectively analyzed measurements of forced vital capacity (FVC) and negative inspiratory force (NIF) in the days before and after PLEX (administered every other day) in patients with MC admitted to a tertiary hospital over 4 years. For multiple measurements in one day, the average value was used. The day immediately before the first treatment with PLEX was considered baseline. Using time as a continuous or categorical variable in mixed-effects multiple linear regressions, we estimated predicted values for these tests. Results Twenty-two patients (mean age 67.3 years, 51.9% male patients) with 27 MC episodes and 508 measurements (234 FVC and 274 NIF; from 5 days before to 20 days after PLEX) were included. Presence of antibodies was detected in 70.4%. Intubation and mechanical ventilation occurred in 36.6% of patients. The mean number of PLEX was 5.1 (range 3–11). NIF values decreased before the first PLEX but increased after by on average 1 cm H2O/day (95% confidence interval [CI] 0.68–1.32, p < 0.001). FVC fluctuated before the first PLEX but then increased by on average 51.2 mL/day (95% CI 35.8–66.1, p < 0.001). The maximum increase in NIF occurred during the day of the first PLEX (9.2 cm H2O, 95% CI 3.3–15.1, p = 0.002) and rather slowed after day 10. FVC increase compared to baseline became significant the second day after the first PLEX (287 mL, 95% CI 7.5–567.6, p = 0.04) and continued overall to increase (with fluctuations) up to day 17. Conclusions Significant increases in bedside respiratory measurements are observed as soon as the first PLEX day but with more variability on FVC than NIF, which may either reflect more FVC technique inconsistencies or more consistent effect of the treatment on NIF.
- 3 April 2025
- Published by Springer Nature in Neurocritical Care
- p. 1-9
Longitudinal Improvement in Respiratory Function Following Plasma Exchange in Patients with Severe Myasthenia Gravis
Background There are no data on the effect size and timing of plasma exchange (PLEX) in patients with myasthenic crisis (MC). Methods We retrospectively analyzed measurements of forced vital capacity (FVC) and negative inspiratory force (NIF) in the days before and after PLEX (administered every other day) in patients with MC admitted to a tertiary hospital over 4 years. For multiple measurements in one day, the average value was used. The day immediately before the first treatment with PLEX was considered baseline. Using time as a continuous or categorical variable in mixed-effects multiple linear regressions, we estimated predicted values for these tests. Results Twenty-two patients (mean age 67.3 years, 51.9% male patients) with 27 MC episodes and 508 measurements (234 FVC and 274 NIF; from 5 days before to 20 days after PLEX) were included. Presence of antibodies was detected in 70.4%. Intubation and mechanical ventilation occurred in 36.6% of patients. The mean number of PLEX was 5.1 (range 3–11). NIF values decreased before the first PLEX but increased after by on average 1 cm H2O/day (95% confidence interval [CI] 0.68–1.32, p < 0.001). FVC fluctuated before the first PLEX but then increased by on average 51.2 mL/day (95% CI 35.8–66.1, p < 0.001). The maximum increase in NIF occurred during the day of the first PLEX (9.2 cm H2O, 95% CI 3.3–15.1, p = 0.002) and rather slowed after day 10. FVC increase compared to baseline became significant the second day after the first PLEX (287 mL, 95% CI 7.5–567.6, p = 0.04) and continued overall to increase (with fluctuations) up to day 17. Conclusions Significant increases in bedside respiratory measurements are observed as soon as the first PLEX day but with more variability on FVC than NIF, which may either reflect more FVC technique inconsistencies or more consistent effect of the treatment on NIF.
- 14 May 2024
- Published by Wolters Kluwer Health in Neurology
- Vol. 102 (9) , e209366
Author Response: Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline: Report of the AAN Guidelines Subcommittee, AAP, CNS, and SCCM
- 14 May 2024
- Published by Wolters Kluwer Health in Neurology
- Vol. 102 (9) , e209366
Author Response: Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline: Report of the AAN Guidelines Subcommittee, AAP, CNS, and SCCM
- Top Cited Papers
- 12 December 2023
- Published by Wolters Kluwer Health in Neurology
- Vol. 101 (24) , 1112-1132
Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline
Background and Objectives The purpose of this guideline is to update the 2010 American Academy of Neurology (AAN) brain death/death by neurologic criteria (BD/DNC) guideline for adults and the 2011 American Academy of Pediatrics, Child Neurology Society, and Society of Critical Care Medicine guideline for infants and children and to clarify the BD/DNC determination process by integrating guidance for adults and children into a single guideline. Updates in this guideline include guidance related to conducting the BD/DNC evaluation in the context of extracorporeal membrane oxygenation, targeted temperature management, and primary infratentorial injury. Methods A panel of experts from multiple medical societies developed BD/DNC recommendations. Because of the lack of high-quality evidence on the subject, a novel, evidence-informed formal consensus process was used. This process relied on the panel experts9 review and detailed knowledge of the literature surrounding BD/DNC to guide the development of preliminary recommendations. Recommendations were formulated and voted on, using a modified Delphi process, according to the 2017 AAN Clinical Practice Guideline Process Manual. Major Recommendations Eighty-five recommendations were developed on the following: (1) general principles for the BD/DNC evaluation, (2) qualifications to perform BD/DNC evaluations, (3) prerequisites for BD/DNC determination, (4) components of the BD/DNC neurologic examination, (5) apnea testing as part of the BD/DNC evaluation, (6) ancillary testing as part of the BD/DNC evaluation, and (7) special considerations for BD/DNC determination.
- 12 December 2023
- Published by Wolters Kluwer Health in Neurology
- Vol. 101 (24) , 1112-1132
Top Cited PapersPediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline
Background and Objectives The purpose of this guideline is to update the 2010 American Academy of Neurology (AAN) brain death/death by neurologic criteria (BD/DNC) guideline for adults and the 2011 American Academy of Pediatrics, Child Neurology Society, and Society of Critical Care Medicine guideline for infants and children and to clarify the BD/DNC determination process by integrating guidance for adults and children into a single guideline. Updates in this guideline include guidance related to conducting the BD/DNC evaluation in the context of extracorporeal membrane oxygenation, targeted temperature management, and primary infratentorial injury. Methods A panel of experts from multiple medical societies developed BD/DNC recommendations. Because of the lack of high-quality evidence on the subject, a novel, evidence-informed formal consensus process was used. This process relied on the panel experts9 review and detailed knowledge of the literature surrounding BD/DNC to guide the development of preliminary recommendations. Recommendations were formulated and voted on, using a modified Delphi process, according to the 2017 AAN Clinical Practice Guideline Process Manual. Major Recommendations Eighty-five recommendations were developed on the following: (1) general principles for the BD/DNC evaluation, (2) qualifications to perform BD/DNC evaluations, (3) prerequisites for BD/DNC determination, (4) components of the BD/DNC neurologic examination, (5) apnea testing as part of the BD/DNC evaluation, (6) ancillary testing as part of the BD/DNC evaluation, and (7) special considerations for BD/DNC determination.
- 15 November 2023
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 52 (2) , e58-e66
The Relationship Between Manifestation of Diabetes Insipidus and Estimated Glomerular Filtration Rate in Brain Death
OBJECTIVES: Systematic reviews have revealed that up to 50% of patients with brain death have residual hypothalamic/pituitary activity based on the absence of central diabetes insipidus (DI). We hypothesized that different degrees of renal dysfunction may impact the presence of DI in patients with brain death. DESIGN: Single-center prospective data collection. SETTING: ICUs in a tertiary academic hospital. PATIENTS: All adult patients declared brain dead over 12 years. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: DI was diagnosed by polyuria, low urine specific gravity, and increasing serum sodium, measured in close proximity. Renal function was assessed by the estimated glomerular filtration rate (eGFR), calculated using the simplified modification of diet in renal disease equation. Analysis was completed in 192 of 234 patients with brain death after excluding those with missing data, those younger than 18 years and those on vasopressin infusions. One hundred twenty-two patients (63.5%) developed DI and 70 patients (36.5%) did not. The proportion of DI decreased significantly with decreasing eGFR: for eGFR greater than 60 mL/min, DI was present in 77.2%; for eGFR 15–60 mL/min, DI was present in 54.5%; for eGFR 14.9–9.8 mL/min, DI was present in 32%; none of the 14 patients with eGFR less than or equal to 9.7 mL/min ever experienced DI (p < 0.001). Using logistic regression, for every 10 mL/min decrease in eGFR, the odds of DI decreased 0.83 times (95% CI, 0.76–0.90, p < 0.001). CONCLUSIONS: Renal dysfunction significantly impacts DI’s clinical manifestation in brain death. We report that patients who experience brain death with severe renal dysfunction may not develop clinical signs of DI.
- 15 November 2023
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 52 (2) , e58-e66
The Relationship Between Manifestation of Diabetes Insipidus and Estimated Glomerular Filtration Rate in Brain Death
OBJECTIVES: Systematic reviews have revealed that up to 50% of patients with brain death have residual hypothalamic/pituitary activity based on the absence of central diabetes insipidus (DI). We hypothesized that different degrees of renal dysfunction may impact the presence of DI in patients with brain death. DESIGN: Single-center prospective data collection. SETTING: ICUs in a tertiary academic hospital. PATIENTS: All adult patients declared brain dead over 12 years. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: DI was diagnosed by polyuria, low urine specific gravity, and increasing serum sodium, measured in close proximity. Renal function was assessed by the estimated glomerular filtration rate (eGFR), calculated using the simplified modification of diet in renal disease equation. Analysis was completed in 192 of 234 patients with brain death after excluding those with missing data, those younger than 18 years and those on vasopressin infusions. One hundred twenty-two patients (63.5%) developed DI and 70 patients (36.5%) did not. The proportion of DI decreased significantly with decreasing eGFR: for eGFR greater than 60 mL/min, DI was present in 77.2%; for eGFR 15–60 mL/min, DI was present in 54.5%; for eGFR 14.9–9.8 mL/min, DI was present in 32%; none of the 14 patients with eGFR less than or equal to 9.7 mL/min ever experienced DI (p < 0.001). Using logistic regression, for every 10 mL/min decrease in eGFR, the odds of DI decreased 0.83 times (95% CI, 0.76–0.90, p < 0.001). CONCLUSIONS: Renal dysfunction significantly impacts DI’s clinical manifestation in brain death. We report that patients who experience brain death with severe renal dysfunction may not develop clinical signs of DI.
- 18 July 2023
- Published by Wolters Kluwer Health in Neurology
- Vol. 101 (3) , 137-139
Must Hypothalamic Neurosecretory Function Cease for Brain Death Determination? No
- 18 July 2023
- Published by Wolters Kluwer Health in Neurology
- Vol. 101 (3) , 137-139
Must Hypothalamic Neurosecretory Function Cease for Brain Death Determination? No
- 1 January 2022
- Published by Springer Nature
- p. 233-244
How Many Evaluations Are Required to Determine Death by Neurologic Criteria?
- 1 January 2022
- Published by Springer Nature
- p. 233-244
How Many Evaluations Are Required to Determine Death by Neurologic Criteria?
- 13 June 2021
- Published by Springer Nature
- p. 359-371
Prevention and Treatment of Traumatic Brain Injury Due to Rapid-Onset Natural Disasters
- 13 June 2021
- Published by Springer Nature
- p. 359-371
Prevention and Treatment of Traumatic Brain Injury Due to Rapid-Onset Natural Disasters
- 1 June 2021
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 88, 16-21
Metabolic values precluding clinical death by neurologic Criteria/Brain death: Survey of neurocritical care society physicians
- 1 June 2021
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 88, 16-21
Metabolic values precluding clinical death by neurologic Criteria/Brain death: Survey of neurocritical care society physicians